[1]
“Molecular Docking Study of α-, β-, and γ-Mangostin from Mangosteen (Garcinia mangostana L.) Targeting VEGFR-2 and NRP-1 for Anti-Angiogenic Therapeutics in Retinopathy Diabetic”, EPHELS, vol. 17, pp. 10–21, Aug. 2025, doi: 10.55549/ephels.145.